Michael James Newman - 22 Dec 2025 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Reporting relationship: CSO and Director, Director
Issuer ticker: INDP
Reported as of: 22 Dec 2025
Net transaction value: +$105,974
SEC form: 4
Accepted by SEC: 29 Dec 2025, 16:01:19 UTC
Prior SEC filing: 10 Oct 2024
Source filing: View source filing
Reporting owner signature: /s/ Michael Newman

Key filing fact

Michael James Newman filed Form 4 for Indaptus Therapeutics, Inc. (INDP) on 29 Dec 2025.

Key facts

This page summarizes Michael James Newman's Form 4 filing for Indaptus Therapeutics, Inc. (INDP).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 29 Dec 2025, 16:01.

Change

Previous filing in this sequence was filed on 10 Oct 2024.
Current net transaction value: +$105,974.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001876315 Primary reporting owner

Newman Michael James

Relationship: CSO and Director, Director
Address: C/O INDAPTUS THERAPEUTICS, INC., 3 COLUMBUS CIRCLE, 15TH FLOOR, NEW YORK
Signature: /s/ Michael Newman
Signature date: 29 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INDP transaction

Common Stock

Award

Transaction value: $105,974
Shares: +52,204
Change %: +107%
Price: $2.03
Shares after: 101,074
Date: 22 Dec 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Reporting Person acquired 52,204 shares of common stock pursuant to an amendment to his employment agreement, in connection with the signing of a securities purchase agreement, dated December 22, 2025.